Which of the following best describes your gender
Toggle navigation
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Track Options
For more information on the scientific content of our track options Click Here
We would like an indication of attendance at each session, please select your preferences below
Day 1 - 18th October 2023
Celullar Technologies for Drug Discovery
Transforming Cancer Drug Discovery
Delving into the diversity of chemistry, driving molecules from concept to clinic
Robotics and Automation: Supporting Collaborative Science
Day 2 - 19th October 2023
Biopharmaceutical discovery
Translating ideas into therapies
HIT identification and screening
Chemistry enabling drug discovery from start to clinic
Toggle navigation
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Additional Scientific Sessions - to reserve your space place select below...
The significance of a comprehensive repository for high-quality biospecimens
Oct 19, 2023 | 0730 - 0845
The session is hosted by Drug Target Review. By registering you are agreeing to share your data with them and the session sponsor who may wish to contact you after the event by email, you may opt-out at any time by using the unsubscribe link in any email you receive. View Drug Target Review’s privacy notice here ,
To view the speakers and agenda click here click here
Oct 17, 2023 | 1000 - 1600
The Splash! Is a unique event for every digital lab enthusiast. It combines an educational part with a hands-on session to try out standards in action. Pick up the details on the popular SiLA and AnIML standards, understand how they work and where you can put them to use. Our hands-on session lets you experience the standards in action firsthand. We’re bringing real and cloud-based instruments and lots of example data sets. Feel free to bring an instrument or your own data.
This session is co-organised by SiLA Consortium and the AnIML Society with the kind support for ELRIG. Attendance is free of charge.
Limited seats - register today!
Diversity in drug discovery strategies calls for diversity in hit finding approaches - supported by WuXi AppTec
Oct 17, 2023 | 1300 - 1500
Recent years have seen a significant expansion in the classes of molecular targets we consider as viable for therapeutic intervention, such as protein-protein interactions, epigenetic targets, RNA targets, nuclear receptors and many more. Alongside this the diversity of modalities we work on has increased to include bifunctional molecules, covalent molecules of varying degrees of reversibility, allosteric modulators, molecular glues and more, in addition to our more traditional small molecule and peptide ligands. This diversity of target types, interaction types and modalities calls for an increasing need to tailor hit finding approaches, and the pool of chemistry in which we search for hits, to the specific discovery strategy in hand.
In this workshop we will discuss recent developments in hit finding approaches that support this tailored approach, including discussion on diverse hit finding techniques, such as fragment screening, ASMS, DNA-encoded library screening and more, as well as the use of these platforms to mine for molecules with affinity, molecules with function, covalent molecules, allosteric binders and peptides. We will discuss protein targets as well as approaches for identifying ligands for RNA.
Toggle navigation
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Poster Submission has now closed
Toggle navigation
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary
Click here to see ELRIG's attendees terms & conditions
Sharing your details with the event exhibitors
Toggle navigation
Cancel
Back
Cancel
Cancel Registration
Next
Next
Return to summary